5:28 PM
 | 
Sep 09, 2013
 |  BC Extra  |  Company News

GSK mum on plans for China unit, investigation

A GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) contact authorized to talk about the company's situation in China did not return calls for comment in the U.S. or Europe related to a pair of recent stories. These included a report last week from Chinese state news agency Xinhua that alleged bribery...

Read the full 223 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >